Maintenance Service for two (2) Illumina NextSeq™ 1000 Sequencers
ID: NIH-CC-OPC-25-000192Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Electronic and Precision Equipment Repair and Maintenance (811210)

PSC

MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT (J066)

Original Source

https://sam.gov/opp/56c75002e7ea4dcd9a5ebef90d60aad4/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Illumina, Inc. for maintenance services on two Illumina NextSeq™ 1000 Sequencers. The contract will cover comprehensive support, including parts, labor, travel, and technical assistance, essential for high-throughput next-generation sequencing used in diagnosing inherited immune disorders. This acquisition is critical as Illumina is the sole manufacturer with the necessary components and expertise to maintain the equipment to its original specifications. Interested parties capable of providing similar services may submit a capability statement to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov, with submissions due by the specified deadline.

    Point(s) of Contact
    Kimala Winfield
    (301) 496-7015
    kimala.winfield@nih.gov
    Malinda Dehner
    (301) 594-6320
    dehnerm@cc.nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Maintenance Service for two (2) Illumina NextSeq™ 1000 Sequencers
    Currently viewing
    Presolicitation
    Similar Opportunities
    MAINTENANCE AND REPAIR SERVICE AGREEMENT FOR NEXTSEQ 2000 (S/N: VH74007)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to negotiate a maintenance and repair service agreement for the Illumina NextSeq 2000 system, serial number VH74007. The contract will cover a 12-month support plan, including full maintenance for parts, labor, and travel, as well as preventative maintenance inspections, remote technical support, and software updates. This service is crucial for the Laboratory of Parasitic Diseases to ensure the operational efficiency of their sequencing equipment. Interested vendors must submit their capability statements and relevant documentation by 12:00 PM EST on November 15, 2024, via the NIH electronic Simplified Acquisition Submission System (eSASS), with all inquiries directed to Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    NextSeq 2000 Silver Support Plan
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to procure a NextSeq 2000 Silver Support Plan from Illumina, Inc. This procurement is essential for maintaining high throughput sequencing capabilities that are critical for research into immune responses against infectious diseases, particularly through RNA sequencing methods. The support plan includes comprehensive service coverage, preventive maintenance, remote technical support, and timely on-site response during the performance period from November 1, 2024, to July 4, 2025. Interested parties must submit capability statements by October 28, 2024, to Angela Puddy at angela.puddy@nih.gov, as this is not a request for proposals and the Government retains discretion regarding competition for this requirement.
    10x Genomics Xenium Analyzer Maintenance Plan
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is planning to award a Firm-Fixed Price purchase order to 10X Genomics, Inc. for the maintenance of the 10x Genomics Xenium instrument, which is critical for clustering single-cell genetic material on tissue sections. This maintenance plan aims to ensure the instrument remains operational and minimizes downtime during repair requests, as 10X Genomics is the sole manufacturer and provider of maintenance support for this proprietary technology. Interested parties who believe they can meet the requirements are invited to submit a written capability statement by 12 p.m. EST on Tuesday, October 29, 2024, to Zetherine Gore at zetherine.gore@nih.gov, referencing Notice ID SS-NIH-7095584 in their correspondence.
    CareDX Lab Solutions Inc. Allo Seq Tx17 Next Generation Sequencing (NGS) Reagent Kits
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to issue a sole source firm fixed-price purchase order to CareDx Lab Solutions Inc. for the procurement of Allo Seq Tx17 Next Generation Sequencing (NGS) reagent kits. This acquisition aims to secure a one-year supply of NGS reagents necessary for the Human Leukocyte Antigen (HLA) Laboratory within the Department of Transfusion Medicine, ensuring adequate stock for patient testing through quarterly shipments scheduled from November 2024 to August 2025. The HLA Laboratory plays a critical role in providing diagnostic testing and consultations for transplant eligibility, maintaining accreditation, and engaging in research for new diagnostic tests. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by October 30, 2024, at 6:30 AM EST, as this is not a request for proposals.
    Miltenyi MACSQuant Tyto Essential Preventative Maintenance Service
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract for the Miltenyi MACSQuant Tyto Essential Preventative Maintenance Service. This contract will establish a one-year preventative maintenance service agreement for the MACSQuant Tyto instrument, which is critical for the manufacturing research and development of cell-based therapies at the NIH Clinical Center. The maintenance service is essential to ensure the operational integrity of the equipment, as any service errors could adversely affect patient care and research outcomes. Interested parties may express their interest and capabilities to Sheri Eiri at sheri.eiri@nih.gov by November 1, 2024, at 12:00 PM EST.
    cDNA-PCR Sequencing Kits for long-read sequencing.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified sources regarding the availability of cDNA-PCR sequencing kits for long-read sequencing, as part of a Sources Sought notice. The primary objective is to procure PromethION flow cells and sequencing kits that are compatible with the Oxford Nanopore PromethION device, which is essential for high-throughput sequencing in research on Alzheimer’s disease and related dementias. These consumables will facilitate the analysis of DNA and RNA samples, aiding in the identification of potential therapeutic targets and biomarkers for Alzheimer's disease. Interested companies must submit their capability statements by October 28, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov, ensuring that all submissions adhere to the specified guidelines and page limits.
    J--NICHD: Service: SH800 Cell Sorter Maintenance
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), intends to award a sole-source contract to Sony Biotechnology for the maintenance of its SH800 Cell Sorter. This maintenance service agreement is crucial for ensuring the optimal functionality of the sorter, which is integral to various genetic and environmental research tasks conducted in NICHD labs. The contract will cover preventive inspections, unlimited technical support, and priority service calls to minimize equipment downtime, with a performance period from December 1, 2024, to November 30, 2025, and options for two additional years. Interested parties may express their capabilities to Nicole Freid at nicole.freid@nih.gov by November 1, 2024, to be considered for any competitive process.
    Qiagen LLC DNA Isolation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure DNA Isolation Kits from Qiagen LLC on a sole source basis. The acquisition aims to supply the Human Leukocyte Antigen (HLA) Lab with essential testing kits that have been rigorously tested to ensure high-quality DNA samples for critical patient testing. These kits are vital for HLA typing, particularly for critically ill patients, as they directly impact the turnaround time for results necessary for lifesaving transplants. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by October 31, 2024, at 6:30 AM EST, as this is not a request for proposals.
    J--GeoMx Maintenance Service Agreement
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), intends to award a non-competitive sole source contract to Bruker Spatial Biology for a GeoMx maintenance service agreement. This agreement is crucial for ensuring the uninterrupted operation of the GeoMx Digital Spatial Profiler (DSP), which plays a vital role in research related to alcohol-induced organ injury and fibrosis models. The maintenance services, covering the period from November 11, 2024, to November 10, 2025, will include annual preventative maintenance, on-site repairs, software updates, and technical support, as Bruker Spatial Biology is the only authorized provider for these services. Interested parties may express their capabilities to fulfill the requirement by submitting responses by October 31, 2024. For further inquiries, contact Nicole T. Freid at nicole.freid@nih.gov or call +1 301 480 6914.
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.